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Equine viral arteritis (EVA) is an endotheliotropic viral disease of horses caused by equine arteritis virus (EAV). Although
there is only one serotype of EAV, there is marked variation in the virulence of different strains of the virus. The replication
and cytopathogenicity of three well-characterized strains of EAV of different virulence to horses were compared in rabbit
kidney (RK-13) and primary equine pulmonary artery endothelial cells (ECs). Viral protein expression, plaque size, and
cytopathogenicity of all three viruses were similar in RK-13 cells, whereas two virulent strains of EAV were readily
distinguished from an avirulent strain by their plaque morphology and cytopathogenicity in primary equine ECs. Furthermore,
EAV nucleocapsid protein was detected by flow cytometric analysis significantly later in ECs infected with the avirulent than
those infected with the virulent strains of EAV. Primary equine ECs provide a convenient and relevant model for in vitroINTRODUCTION
Equine arteritis virus (EAV) is the causative agent of
equine viral arteritis (EVA), a reproductive and respiratory
disease of horses (Timoney and McCollum, 1993). The
virus was first isolated in 1953 from the lung of an
aborted equine fetus during an abortion storm on a farm
in Bucyrus, Ohio (Doll et al., 1957). EAV is a positive-
stranded RNA virus and is the prototype member of the
genus Arterivirus in the family Arteriviridae of the order
Nidovirales (Cavanagh, 1997). Other viruses in this ge-
nus include lactate dehydrogenase elevating virus of
mice, simian hemorrhagic fever virus, and porcine repro-
ductive and respiratory syndrome virus. There is only
one serotype of EAV and all strains are neutralized by
polyclonal antiserum to the virulent Bucyrus strain of EAV
(Balasuriya et al., 1997); however, geographically and
temporally distinct strains of EAV differ in the severity of
the disease they induce in horses and in their aborti-
genic potential (McCollum and Timoney, 1999; Patton et
al., 1998; Timoney and McCollum, 1993). The majority of
field strains of EAV cause subclinical or inapparent in-
fection in horses, whereas other strains cause the clin-
ical manifestations of EVA (MacLachlan et al., 1996; Mc-
Collum et al., 1971; McCollum and Timoney, 1999;
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Pathology, Microbiology and Immunology, School of Veterinary Medi-39Timoney and McCollum, 1993). EAV principally replicates
in macrophages and endothelium in infected horses, and
the clinical manifestations of EVA reflect endothelial in-
jury (Crawford and Henson, 1973; MacLachlan et al.,
1996). The characteristic vascular lesion of severe EVA is
panvasculitis, with necrosis and leukocytic infiltration of
medium and small muscular arteries (Crawford and Hen-
son, 1973; Jones et al., 1957; MacLachlan et al., 1996).
Although EAV infects endothelial cells, the mechanism of
EAV-induced vascular injury is poorly characterized.
Thus, in an effort to develop a cell culture system in
which to further characterize the virulence determinants
of EAV and the pathogenesis of EVA, we compared the
replication and cytopathogenicity of virulent and aviru-
lent strains of EAV in rabbit kidney (RK-13) and primary
equine pulmonary artery endothelial cells (ECs).
RESULTS AND DISCUSSION
Pure cultures of primary equine pulmonary artery ECs
with characteristic cobblestone morphology were iso-
lated and propagated. Immunofluorescence staining for
Factor VIII in perinuclear granules (Weibel-Palade bod-
ies), uptake of 1,1-dioctadecyl-3, 3,3, 3-tetramethylindo-
carbocyanine perchlorate conjugated to acetylated low-
density lipoprotein (DiI-Ac-LDL), and lipopolysaccharide
(LPS)-induced E-selectin expression established the
identity of the cultured cells as ECs. The lack of anycharacterization of the pathogenesis of EVA and the virule
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desmin confirmed the purity of the cultures. EC cultures
were strongly contact inhibited, and maintained their
phenotype and staining for Factor VIII for greater than 30
passages. All three strains of EAV (ATCC, Manasses, VA,
KY84, and CA95) caused a lytic infection in both RK-13
and primary equine ECs; however, the onset and extent
of cytopathic effect (CPE) varied markedly in EC cultures
inoculated with the different viruses. The onset of CPE
was especially delayed in EC cultures inoculated with
the avirulent CA95 strain of EAV, and complete CPE
never developed in these cultures. The ATCC and KY84
strains of EAV, which respectively cause severe and
moderately severe EVA in horses, replicated more rap-
idly and to a higher titer in ECs than did the avirulent
CA95 virus that causes inapparent infection of horses
(Fig. 1). The ATCC and KY84 strains of EAV produced
significantly larger plaques in ECs than did the avirulent
CA95 strain (P  0.001; Table 1, Figs. 2a and 2b), and the
highly virulent ATCC strain of EAV also produced signif-
icantly larger plaques than did the moderately virulent
KY84 strain (P 0.001). In distinct contrast, there was no
difference in the size of the plaques produced by any of
these three strains of EAV in RK-13 cells.
The incidence of infection (percentage of infected
cells) also was significantly different in EC cultures in-
oculated with the virulent and avirulent strains of EAV, as
determined by expression of the EAV nucleocapsid (N)
protein (Fig. 3). Specifically, the incidence of N-protein
expression was significantly higher at 12, 24, 36, and
48 h postinfection (h.p.i.) in EC cultures infected with the
highly virulent ATCC and moderately virulent KY84
strains than that in cultures infected with the avirulent
FIG. 1. Replication of an avirulent (CA95) and two virulent (ATCC, KY84) strains of EAV. Confluent monolayers of primary equine ECs were infected
with partially purified preparations of each strain of EAV at an m.o.i. of 5.0 and virus titers (PFU/ml) were determined in sonicated whole cell lysates
at the intervals after infection that are shown.
TABLE 1
Origin, Passage History, Plaque Morphology, and Virulence to Horses of Strains of EAV
Virus Origin
Year
isolated
Horse
breeda
Cell type and
passage historyb
Plaque diameter (mm)
Severity of clinical
disease in inoculated horsesRK-13 EC
ATCC American Type
Culture Collection
1953 STD Eq 15, LLC-MK1, BHK 1, RK 2 3.58 3.67 Severec
KY84 Kentucky 1984 TB RK 3 3.46 2.31 Moderately severed
CA95 California 1995 STD RK 3 3.47 1.16 Subclinicale
a Horse breeds: TB, thoroughbred; STD, standardbred.
b Cells: RK, rabbit kidney-13; LLC-MK, rhesus monkey kidney cell line 2; BHK, baby hamster kidney 21; Eq 15, 15 serial passages in horses. Passage
history: each cell type is followed by the number of passages in that cell type.
c Crawford and Henson (1973); Jones et al., (1957); MacLachlan et al. (1996); McCollum et al. (1971).
d McCollum and Timoney (1984); Balasuriya et al. (2002).
e Patton et al. (1998).
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CA95 strain (P  0.001). There were no significant dif-
ferences in the incidence of N-protein expression at any
time interval after infection of RK-13 cells with these
three strains of EAV.
Necrosis was the exclusive cause of cell death in both
ECs and RK-13 cells infected with all three strains of EAV,
and there were significant differences in the incidence of
necrosis in EC cultures infected with the virulent and
avirulent strains (Fig. 3). The highly virulent ATCC strain
caused significantly more cytolysis at 36 (P  0.003) and
48 (P  0.016) hpi than did the moderately virulent KY84
strain. Similarly, both the highly virulent ATCC and mod-
erately virulent KY84 viruses induced more cytolysis at
36, 48, and 72 h.p.i. (P  0.001) than did the avirulent
FIG. 2. (a) Size of plaques produced by the highly virulent ATCC, moderately virulent KY84, and avirulent CA95 strains of EAV in primary equine ECs
and rabbit kidney (RK-13) cells. The vertical bars represent the mean  standard deviation. An asterisk indicates a statistically significant difference
(P  0.001) in mean plaque diameter between the strains of EAV. (b) Plaque morphology of three strains of EAV in ECs (top row) and RK-13 (bottom
row) cells.
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CA95 virus. In contrast, the virulent and avirulent strains
of EAV were not distinguished at any time interval after
infection by the incidence of necrosis they induced in
RK-13 cells.
Genetic variation and differences in virulence have
been repeatedly demonstrated among field isolates and
laboratory strains of EAV (Balasuriya et al., 1995, 1998;
Hedges et al., 1996; McCollum and Timoney, 1999; Patton
et al., 1998). Thus, the objective of this study was to
determine if the growth characteristics in primary equine
ECs of three well-characterized strains of EAV were pre-
dictive of their virulence to horses. We clearly demon-
strate, for the first time, differences in the replication and
cytopathogenicity in equine ECs between EAV strains of
different virulence to horses. Whereas replication of the
different strains of EAV was not distinguished by plaque
morphology, viral protein expression, or cytopathogenic-
ity in RK-13 cells, the highly virulent ATCC, moderately
virulent KY84, and avirulent CA95 strains of EAV were
readily distinguished by their growth in equine ECs and
this grouping precisely correlates to the virulence of
each strain to horses (Balasuriya et al., 2002; Mac-
Lachlan et al., 1996; McCollum and Timoney, 1999; Patton
et al., 1998). Thus, the data confirm that differences in the
virulence to horses of these strains of EAV may be
predicted by in vitro assay in primary equine ECs.
In summary, whereas RK-13 cells provide a convenient
and sensitive system for isolation and amplification of
field strains of EAV (McCollum et al., 1962), growth char-
acteristics of different strains of EAV in this cell line are
not predictive of their virulence to horses. In contrast,
primary equine ECs provide a very relevant model for in
vitro characterization of the virulence determinants of
EAV and the pathogenesis of EVA.
MATERIALS AND METHODS
Cells and viruses
The isolation and purification of primary equine ECs
using repeated fluorescence-activated cell sorting based
on the uptake of Dil-Ac-LDL (Biomedical Technologies,
Stoughton, MA) has been previously described in detail
FIG. 3. Incidence (%) of infection and necrosis in primary equine ECs and rabbit kidney (RK-13) cells infected with the three strains of EAV, as
determined by flow cytometric analysis. Vertical bars represent the mean  standard deviation. Data were analyzed by repeated measures one-way
ANOVA followed by post-hoc Tukey’s multiple comparison. Significant differences in the percentage of infected cells between virulent (ATCC and
KY84) and avirulent (CA95) strains of EAV occur at 12 (P  0.01), 24 (P  0.001), 36 (P  0.001), and 48 (P  0.001) h.p.i. Incidence of necrosis in ECs
infected with the three strains of EAV as detected by propidium iodide exclusion (PI) and flow cytometric analysis significantly differs (P  0.001)
between virulent (ATCC and KY84) and avirulent (CA95) strains of EAV at 36, 48, and 72 h.p.i. There was no significant difference in the incidence of
infection or necrosis in RK-13 cells infected with the virulent and avirulent strains of EAV.
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(Hedges et al., 2001). The purity of the EC cultures was
confirmed by immunofluorescence staining with a panel
of Mabs (DAKO Corp., Carpinteria, CA) that recognize
epithelial and mesothelial cells (Mabs AE1/AE3, cytok-
eratin-specific), pericytes (Mab D33, desmin-specific),
and smooth muscle cells (Mab 1A4, actin-specific). An-
tibody binding was detected with fluorescein isothiocya-
nate (FITC)-conjugated secondary antibody (Sigma, St.
Louis, MO) by fluorescence microscopy and flow cyto-
metric analysis using a FACScan instrument (Becton–
Dickinson, San Jose, CA). The purified ECs were further
characterized by immunofluorescence staining with rab-
bit antiserum to von Willebrand factor (Factor VIII; DAKO
Corp.), the identification of Weibel-Palade bodies, which
are highly characteristic of ECs, and by LPS-induced
E-selectin expression (Hedges et al., 2001). ECs were
maintained in endothelial cell maintenance medium
(Dulbecco’s modified essential medium with sodium
pyruvate; Mediatech, Herndon, VA), 10% heat-inactivated
fetal bovine serum (HyClone Laboratories, Inc., Logan,
UT), antibiotics, nonessential amino acids, and 200 mM
L-glutamine (Sigma). All experiments were performed on
EC cultures between passages 5 and 15. RK-13 (ATCC
CCL 37) cells were maintained in minimal essential me-
dium with Earle’s salts (EMEM) supplemented with 10%
calf serum (Hyclone Laboratories, Inc.) and antibiotics.
The viruses compared in this study included the highly
virulent (velogenic) ATCC strain of EAV (ATCC VR-796),
which was derived by serial inoculation of horses with
the original 1953 Bucyrus isolate of EAV; the moderately
virulent KY84 strain of EAV that was isolated during an
outbreak of EVA among thoroughbred horses in Kentucky
in 1984; and the avirulent CA95 strain of EAV that was
isolated from the semen of a persistently infected carrier
standardbred stallion in California (Table 1). We and
others have previously comprehensively defined the vir-
ulence to horses of each of the three strains of EAV used
in this study (Balasuriya et al., 2002; Crawford and Hen-
son, 1973; Jones et al., 1957; MacLachlan et al., 1996;
McCollum et al., 1971; McCollum and Timoney, 1984,
1999; Patton et al., 1998). Each virus was passaged once
in RK-13 cells to prepare a partially purified stock. Briefly,
RK-13 cells infected with each virus were frozen at
70°C after appearance of CPE. Cell lysates were clar-
ified by low-speed centrifugation (1700 g), and the virus
was pelleted by ultracentrifugation at 121,600 g through a
20% sucrose cushion in NET buffer (150 mM NaCl, 5 mM
EDTA, and 50 mM Tris–HCl, pH 7.5) at 4°C for 4 h.
Partially purified preparations of each strain of EAV were
resuspended in EMEM and frozen at 70°C. The titer of
each virus stock was determined as plaque-forming
units (PFU)/ml in RK-13 cells. Similar preparations of
uninfected RK-13 cells were prepared for mock infection
of ECs.
Replication of EAV strains
The replication of the three strains of EAV was com-
pared in equine ECs and RK-13 cells using plaque size,
one-step growth curves, and infection rate (percentage
of infected cells in each culture) as determined by ex-
pression of the N-protein of EAV. To determine plaque
size, each virus was adsorbed for 1 h to confluent cul-
tures of either ECs or RK-13 cells and the cultures were
then overlaid with 0.75% carboxymethylcellulose (Sigma)
containing maintenance medium. The monolayers were
incubated for 96 h and fixed and stained with 1% crystal
violet containing 1% formaldehyde. Replication of the
three strains of EAV was compared in ECs that were
infected with partially purified virus at a m.o.i. of 5.0 and
incubated at 37°C. Individual cultures were harvested at
1, 6, and 12 and at subsequent 12-h intervals for 72 h.p.i.
and titers of virus in sonicated culture lysates were
determined by plaque assay on RK-13 cells essentially
as previously described (McCollum et al., 1962). Flow
cytometric analysis after immunofluorescence staining
for the N-protein of EAV was used to determine the
percentage of EAV-infected cells in each culture. Briefly,
ECs and RK-13 cells were infected with partially purified
EAV at an m.o.i. of 5, and individual cultures were har-
vested at 12-h intervals after infection. Adherent cells
remaining in each flask were removed by trypsinization,
pooled with those previously detached from the media,
and washed once with phosphate-buffered saline prior
to fixation with 4% paraformaldehyde. Cells were then
permeabilized with 0.1% saponin (Sigma) (Lavigne et al.,
1997). The presence of the N-protein of EAV was de-
tected in infected cells by labeling with the N-protein-
specific Mab 3E2 (MacLachlan et al., 1996) followed
by FITC-conjugated goat antimouse immunoglobulin
(Sigma). Mock-infected cultures were harvested at 12,
24, 36, and 72 h for comparison.
Cell death in EC and RK-13 cultures infected with
different strains of EAV
The incidence of cell death in EAV-infected EC and
RK-13 cell cultures was quantitated by determining the
percentage of apoptotic and/or necrotic cells in each
culture at 12-h intervals after infection. Apoptosis and
necrosis, respectively, were quantitated by double-
label flow cytometric analysis based on the binding of
annexin-V (R&D Systems, Minneapolis, NE) and the
exclusion of propidium iodide (Sigma), as previously
described (Vermes et al., 1995). Forward light scatter
and side light scatter characteristics on flow cytomet-
ric analysis also were used to determine the percent-
age of cytolysis in each culture and to further distin-
guish apoptotic from necrotic cells (Darzynkiewicz,
1997).
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Data analysis
Data were analyzed with the CELLQuest version 3.1
(Becton–Dickinson, San Jose, CA) and MINITAB (Minitab
Inc., State College, PA) software packages. All experi-
ments were repeated at least five times and the data
from replicate experiments were compared at 1, 12, 24,
36, 48, and 72 h.p.i. Mean values and standard devia-
tions were calculated for each parameter with a re-
peated measures one-way ANOVA (parametric analysis
of population means) to determine differences between
mean values of the data at each time point. Differences
were considered significant at P  0.05. If the overall
ANOVA was significant, a post-hoc Tukey’s multiple com-
parison of the mean was performed on data at each time
point to evaluate differences between the various EAV
strains.
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